Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

✍ Scribed by Llovet, J. M.; Decaens, T.; Raoul, J.-L.; Boucher, E.; Kudo, M.; Chang, C.; Kang, Y.-K.; Assenat, E.; Lim, H.-Y.; Boige, V.; Mathurin, P.; Fartoux, L.; Lin, D.-Y.; Bruix, J.; Poon, R. T.; Sherman, M.; Blanc, J.-F.; Finn, R. S.; Tak, W.-Y.; Chao, Y.; Ezzeddine, R.; Liu, D.; Walters, I.; Park, J.-W.

• Book ID: 124089989
• Publisher: American Society of Clinical Oncology
• Year: 2013
• Tongue: English
• Weight: 229 KB
• Volume: 31
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2012.47.3009